Following PharmaMar’s success on the stock market, what can investors expect in 2021?

You can also listen to us

All the episodes of ‘The clear accounts’ are on the Cuonda website. You can also listen to them on Spotify, Apple and Ivoox.

The biotech company PharmaMar is one of the values ​​preferred by investors of the Ibex 35 in this 2020. Despite his brilliant career on the Stock Market – he has gained more than 100% since January – his year has been marked by the volatility and for the odd doubt. In this third episode of the podcast The Clear Accounts we spoke with Darío García, Analist of XBT, on those doubts and on the prospects of its actions for the coming months.

In addition, we look to Brussels, where EU leaders are meeting this week to try to push forward the anti covid recovery fund, and to Frankfurt, where the monthly meeting of the ECB.

Back in Spain, we will analyze the latest bankruptcy case in a dental franchise after others such as iDental or Funydent: Dentix. Hundreds of thousands of people have been left without treatment and without money. From Facua they answer us about what claim options these clients have and what is wrong with this type of business so that they fail over and over again in Spain.

You may also like